Two pillars of cardiovascular disease detection and treatment come together. Their goal is to integrate Cleerly's advanced AI-based coronary artery assessment technology (which irrigates the heart) with the Cardiac Care Alliance cardiovascular care network in Texas and California. The latter, by facilitating rapid access to quality care for providers, insurers and patients, improves outcomes while optimizing costs.
Cardiac Care Alliance is committed to proactive, personalized and patient-centered cardiovascular medicine, aimed at making care more seamless and accessible. The aim of this partnership is for symptomatic patients to benefit, where relevant, from an assessment via Cleerly prior to any cardiac catheterization procedure (insertion of a small tube into an artery to explore the heart). This will enable only those patients who need the procedure to be referred to the catheterization laboratory, while avoiding unnecessary examinations and additional costs for patients who do not. Deployment will begin with cardiology practices in Texas, before being rolled out more widely across the US.
"By detecting coronary disease more accurately and non-invasively, we can guide personalized treatment decisions that improve outcomes while reducing costs. At a time when cardiovascular spending could exceed $1 trillion by 2035 as the population ages, and re-hospitalizations for cardiac conditions are among the most frequent and costly for Medicare [the US federal health insurance program], we are focusing our efforts on a simple fact: many cardiovascular pathologies are treatable if detected early - potentially saving a large number of lives," explains Dr James Min, Cleerly's founder and CEO.
Cleerly's mission is to redefine the standards of care for heart-related diseases. Thanks to its AI-powered solutions approved by the FDA (Food and Drug Administration, which regulates and authorizes the marketing of many healthcare products in the USA), Cleerly enables in-depth characterization of coronary artery disease based on non-invasive imaging. Its scientific approach is based on the analysis of millions of images from over 40,000 patients.
